معرفی
Terry Lim is a Research Fellow in the Department of Biochemistry & Molecular Biology at Monash University, actively contributing to cutting-edge research in biochemistry, immunology, and cancer biology. His work integrates proteomics and phosphoproteomics to explore disease mechanisms and therapeutic targets.
- Doctor of Philosophy, Monash University (2020)
- Bachelor of Biotechnology (Medical Biotechnology) with Honours, Monash University (2013)
His research focuses on biochemistry, immunology, autoimmunity, cancer biology, proteomics, and mass spectrometry. He investigates molecular mechanisms in diseases such as ankylosing spondylitis and various cancers, using advanced omics technologies to uncover signaling networks and biomarkers. His recent work spans pediatric cancers, spaceflight-induced renal dysfunction, and immunometabolism.
Terry Lim's recent publications (2023–2024) in journals like Nature Communications and Cell Reports highlight his expertise in phosphoproteomics and intercellular signaling. His research trends emphasize translational molecular biology, with applications in oncology, autoimmune disorders, and space medicine. Articles explore topics such as MHC-I regulation, glucagon metabolism, and tumor microenvironment dynamics.
He is a Chief Investigator on two NHMRC equipment grants focused on advanced proteomics instrumentation, demonstrating active grant involvement. While no formal students are listed, his collaborative research includes work with senior investigators and multidisciplinary teams.
Terry Lim contributes to research networks in cancer, immunology, and space health, collaborating on pan-omic and physiological studies. His lab environment is embedded within Monash’s biochemistry and molecular biology research infrastructure, supporting high-throughput proteomic analysis and translational discovery.
